+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Structural Heart Devices Market - Forecasts from 2019 to 2024

  • PDF Icon


  • 108 Pages
  • October 2019
  • Region: Global
  • Knowledge Sourcing Intelligence LLP
  • ID: 4858278
Structural heart disease is referred to a defect or an abnormality in the heart structure which in later life of an individual may interfere with the normal heart functioning. Hence, this needs to be rectified as soon as detected, driving market growth in the forecast period. Thus, the prevalence of structural heart diseases is one of the major drivers driving the growth of the global structural heart devices market. Additionally, regulatory approvals for advanced structural heart devices and growing awareness regarding the structural heart diseases are further driving the market growth worldwide in the forecast period and in the coming years.

The structural heart devices market is expected to grow at a CAGR of 12.08% to achieve a market size of USD8.918 billion in 2024. Geographically, the North American region is expected to hold a significant market share due to the highest health expenditure of the United States among all the industrialized regions of the world followed by the Asia Pacific region, which is expected to be the fastest-growing. Furthermore, the growing adoption of minimally invasive procedures are further providing an opportunity for the market to thrive in the upcoming years

The Structural Heart Devices Market - Forecasts from 2019 to 2024 is an exhaustive study which aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, component, platform, and geography.

The structural heart devices market has been segmented based on product type, procedure, and geography. Based on product type, the market has been segmented into heart valve devices and occluders. By procedure, the market is segmented into cardiac catherizatiom/ minimally invasive and open heart surgery.

Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa (MEA), and the Asia Pacific regions. The report also analyzes 15 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.

Major players in the structural heart devices market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the structural heart devices market.


The structural heart devices market has been analyzed through the following segments:

By Product Type
  • Heart Valve Devices
  • Occluders
  • PFO Occluders
  • ASD Occluders
  • VSD Occluders
  • LAA Occluders

By Procedure
  • Cardiac Catherization/Minimally Invasive
  • Open Heart Surgery

By Geography

North America
  • USA
  • Canada
  • Mexico

South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Others

Middle East and Africa
  • Saudi Arabia
  • Israel
  • Others

Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Others

Table of Contents

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2.1. Research Design
2.2. Secondary Sources
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter's Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis- Regional Snapshot
4.7. Market Attractiveness
5.1. Heart Valve Devices
5.2. Occluders
5.1.1. PFO Occluders
5.1.2. ASD Occluders
5.1.3. VSD Occluders
5.1.4. LAA Occluders
6.1. Cardiac Catheterization/Minimally Invasive
6.2. Open Heart Surgery
7.1. North America
7.1.1. USA
7.1.2. Canada
7.1.3. Mexico
7.2. South America
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. Germany
7.3.2. France
7.3.3. UK
7.3.4. Spain
7.3.5. Others
7.4. Middle East and Africa
7.4.1. Saudi Arabia
7.4.2. Israel
7.4.3. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. South Korea
7.5.4. India
7.5.5. Others
8.1. Competitive Benchmarking and Analysis
8.2. Recent Investments and Deals
8.3. Strategies of Key Players
11.1. Edwards Lifesciences Corporation
11.2. Medtronic
11.3. Abbott
11.4. Boston Scientific Corporation or its affiliates
11.5. LivaNova PLC
11.6. CryoLife, Inc.
11.7. Micro Interventional Devices, Inc.
11.8. Braile Biomédica
11.9. TTK Healthcare Limited
11.10. Lepu Medical Technology (Beijing) Co., Ltd.

Companies Mentioned

  • Edwards Lifesciences Corporation
  • Medtronic
  • Abbott
  • Boston Scientific Corporation or its affiliates
  • LivaNova PLC
  • CryoLife, Inc.
  • Micro Interventional Devices, Inc.
  • Braile Biomédica
  • TTK Healthcare Limited
  • Lepu Medical Technology (Beijing) Co., Ltd.